Home Institutions Northwestern Medicine clinical trials Institution Directory
Clinical trials at Northwestern Medicine Sites in Chicago, IL
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 31, 2026, 8:10 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1129
Current sort
Recently updated
Campus scope
Northwestern Medicine, Chicago, IL
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 793–804 of 1,129 matching trials with a site at Northwestern Medicine, Chicago, IL.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma
Interventions Magnetic Resonance Imaging, Prophylactic Cranial Irradiation Procedure · Radiation
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 668 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2029
U.S. locations 428
States / cities Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 328 more
Conditions Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Interventions Cytarabine, Idarubicin Hydrochloride, Navtemadlin Drug
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 24 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2027
U.S. locations 6
States / cities Los Angeles, California • Chicago, Illinois • Baltimore, Maryland + 2 more
Conditions Acute Myeloid Leukemia (AML)
Interventions Azacitidine, Venetoclax, Placebo Drug
Lead sponsor AbbVie Industry
Eligibility 18 Years and older
Enrollment 443 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2026
U.S. locations 24
States / cities Duarte, California • Los Angeles, California • Sacramento, California + 17 more
Conditions Cervical Cancer, Breast Cancer, Colon Cancer, NSCLC, mCRPC (Metastatic Castration-resistant Prostate Cancer), Glioblastoma, Nonsmall Cell Lung Cancer
Interventions ²¹²Pb-DOTAM-GRPR1 Drug
Lead sponsor Orano Med Theranostics, SAS Industry
Eligibility 18 Years and older
Enrollment 48 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2032
U.S. locations 8
States / cities Chicago, Illinois • Iowa City, Iowa • Lexington, Kentucky + 3 more
Conditions Resectable Intrahepatic Cholangiocarcinoma
Interventions Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Futibatinib, Gemcitabine, Magnetic Resonance Imaging Procedure · Drug · Biological
Lead sponsor Northwestern University Other
Eligibility 18 Years and older
Enrollment 44 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2027 – 2031
U.S. locations 1
States / cities Chicago, Illinois
Conditions Amputation of Lower Limb
Interventions Prosthetic foot, Physical therapy Other
Lead sponsor Northwestern University Other
Eligibility 18 Years and older
Enrollment 50 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2029
U.S. locations 1
States / cities Chicago, Illinois
Conditions Postpartum
Interventions Participant will view a visual aid picture (appendix A) first, Participant will view a visual aid picture (appendix B) first Other
Lead sponsor Northwestern University Other
Eligibility 18 Years and older · Female only
Enrollment 40 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 1
States / cities Chicago, Illinois
Conditions Vitiligo, Healthy
Interventions Not listed
Lead sponsor Northwestern University Other
Eligibility 18 Years to 89 Years
Enrollment 100 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2019 – 2026
U.S. locations 1
States / cities Chicago, Illinois
Conditions Brain Metastases
Interventions Memantine, Hippocampal-avoidant (HA-WBRT) Radiotherapy, Stereotactic Radiosurgery (SRS) Drug · Radiation · Procedure
Lead sponsor Canadian Cancer Trials Group Network
Eligibility 18 Years and older
Enrollment 206 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2027
U.S. locations 73
States / cities Tucson, Arizona • Corona, California • Duarte, California + 63 more
Conditions Hereditary Pancreatic Cancer, Conditions or Focus of Study, Hereditary Breast Cancer, Hereditary Colorectal Cancer
Interventions Implementation strategies Behavioral
Lead sponsor Josh Peterson Other
Eligibility Not listed
Enrollment 1,000 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2026 – 2030
U.S. locations 10
States / cities Los Angeles, California • Orlando, Florida • Decatur, Georgia + 7 more
Conditions Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7
Interventions Ipilimumab, Laboratory Biomarker Analysis, Nivolumab, Quality-of-Life Assessment, Questionnaire Administration Biological · Other
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 275 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2015 – 2027
U.S. locations 1201
States / cities Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 735 more
Conditions Delayed Sleep-Wake Phase Disorder
Interventions Light and Citalopram Combination Product
Lead sponsor Northwestern University Other
Eligibility 16 Years and older
Enrollment 220 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 1
States / cities Chicago, Illinois About this Northwestern Medicine institution page
What this page lists ClinicalTrials.gov records that list Northwestern Medicine in Chicago, IL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by Northwestern University at any site , browse by condition , or browse by U.S. city .